In tumor tissue, PD-1 blockade combined with B. bre JCM92 significantly increased the CD8+ T cell level and the CD8+/Treg ratio compared to PD-1 blockade alone (Figure 5A). This evidence concerns the gene PDCD1 and neoplasm.